These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38748222)

  • 1. Long-Term Compliance of Self-Care Pessary in Symptomatic Pelvic Organ Prolapse.
    Charoenloet N; Srisukho S; Phongnarisorn C; Tongsong T; Rujijanakul Y
    Int Urogynecol J; 2024 Jun; 35(6):1263-1269. PubMed ID: 38748222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaginal ring pessary use for pelvic organ prolapse: continuation rates and predictors of continued use.
    Manonai J; Sarit-Apirak S; Udomsubpayakul U
    Menopause; 2018 Dec; 26(6):665-669. PubMed ID: 30562318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term adherence to pessary use in women with pelvic organ prolapse: A retrospective cohort study.
    Koch M; Carlin G; Lange S; Umek W; Krall C; Bodner-Adler B
    Maturitas; 2023 Dec; 178():107828. PubMed ID: 37659128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term continuations rate of ring pessary use for symptomatic pelvic organ prolapse.
    Manchana T
    Arch Gynecol Obstet; 2024 May; 309(5):2203-2209. PubMed ID: 38189963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with long-term pessary use in women with symptomatic pelvic organ prolapse.
    Mao M; Xu T; Kang J; Zhang Y; Ai F; Zhou Y; Zhu L
    Climacteric; 2019 Oct; 22(5):478-482. PubMed ID: 30897024
    [No Abstract]   [Full Text] [Related]  

  • 6. Discontinuation rate and adverse events after 1 year of vaginal pessary use in women with pelvic organ prolapse.
    Yimphong T; Temtanakitpaisan T; Buppasiri P; Chongsomchai C; Kanchaiyaphum S
    Int Urogynecol J; 2018 Aug; 29(8):1123-1128. PubMed ID: 28815277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-care of vaginal pessary for pelvic organ prolapse: a systematic review and meta-analysis.
    Ruffolo AF; Lallemant M; Aurore D; Kerbage Y; Rubod C; Cosson M
    Arch Gynecol Obstet; 2024 Jun; 309(6):2367-2380. PubMed ID: 38634900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful long-term use of Gellhorn pessary and the effect on symptoms and quality of life in women with symptomatic pelvic organ prolapse.
    Mao M; Ai F; Kang J; Zhang Y; Liang S; Zhou Y; Zhu L
    Menopause; 2019 Feb; 26(2):145-151. PubMed ID: 30130292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of pessary use in women aged 65 - 74 versus 75 years and older with pelvic organ prolapse: a 12-year study.
    Ramsay S; Tu le M; Tannenbaum C
    Int Urogynecol J; 2016 Aug; 27(8):1201-7. PubMed ID: 26872647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaginal pessary continuation in symptomatic pelvic organ prolapse patients with prior hysterectomy.
    Ma C; Kang J; Xu T; Zhang Y; Ma Y; Liang S; Hui Y; Wang Y; Zhu L
    Menopause; 2020 Oct; 27(10):1148-1154. PubMed ID: 32881830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ring pessary for all pelvic organ prolapse.
    Manchana T
    Arch Gynecol Obstet; 2011 Aug; 284(2):391-5. PubMed ID: 20848116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is hysterectomy or prior reconstructive surgery associated with unsuccessful initial trial of pessary fitting in women with symptomatic pelvic organ prolapse?
    Nemeth Z; Farkas N; Farkas B
    Int Urogynecol J; 2017 May; 28(5):757-761. PubMed ID: 27796427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to support pessary in the treatment of pelvic organ prolapse: a retrospective study conducted among 1,371 women.
    Brandt CH; Yamolaei M; Wu C; Hansen UD; Rasch V
    Int Urogynecol J; 2024 Jan; 35(1):69-75. PubMed ID: 37548745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with unsuccessful pessary fitting in women with symptomatic pelvic organ prolapse: Systematic review and metanalysis.
    de Albuquerque Coelho SC; Brito LGO; de Araujo CC; Juliato CRT
    Neurourol Urodyn; 2020 Sep; 39(7):1912-1921. PubMed ID: 32649024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with unsuccessful pessary fitting and reasons for discontinuation in Korean women with pelvic organ prolapse.
    Oh S; Namkung HR; Yoon HY; Lee SY; Jeon MJ
    Obstet Gynecol Sci; 2022 Jan; 65(1):94-99. PubMed ID: 34897264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-line treatment of pelvic organ prolapse and discontinuation of pessary treatment.
    Umachanger JK; Marcussen ML; Bøggild H; Kjærgaard N; Glavind K
    Int Urogynecol J; 2020 Sep; 31(9):1813-1819. PubMed ID: 32447418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ring and Gellhorn pessaries used in patients with pelvic organ prolapse: a retrospective study of 8 years.
    Yang J; Han J; Zhu F; Wang Y
    Arch Gynecol Obstet; 2018 Sep; 298(3):623-629. PubMed ID: 29978415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors for long-term adherence to vaginal pessary in pelvic organ prolapse: a prospective study.
    Niigaki DI; Silva RSP; Bortolini MAT; Fitz FF; Castro RA
    Int Urogynecol J; 2022 Nov; 33(11):3237-3246. PubMed ID: 35286427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The usage of Gellhorn pessary in pelvic organ prolapse and in regards to success, continuity of use and effect on symptoms: a retrospective study of 2 years.
    Ramanujam S; Balakrishnan S
    Med J Malaysia; 2023 Nov; 78(6):705-710. PubMed ID: 38031210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pessaries (mechanical devices) for managing pelvic organ prolapse in women.
    Bugge C; Adams EJ; Gopinath D; Stewart F; Dembinsky M; Sobiesuo P; Kearney R
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD004010. PubMed ID: 33207004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.